2018 annual financial data

Cartesian Therapeutics 2018 Net margin

Cartesian Therapeutics 2018 net margin with verified reported values.

Direct answer

Net margin was -7,235.44%.

Operating income was -65,022,000 USD and net income was -65,336,000 USD.
Operating cash flow was -59,161,000 USD.

Get free Cartesian Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
903,000 USD
Operating income
-65,022,000 USD
Net income
-65,336,000 USD
Operating cash flow
-59,161,000 USD